| 中文别名： |
(2-甲基丙基)硼酸(1S,2S,3R,5S)-(+)-2,3-蒎烷二醇酯;(3aS,4S,6S,7aR)-2-异丁基-3a,5,5-三甲基六氢-4,6-桥亚甲基-1,3,2-苯并二氧杂环戊硼烷;2-甲基丙基硼酸(1S,2S,3R,5S)-(+)-2,3-蒎烷二醇酯;2-甲基丙烷硼酸-(1S,2S,3R,5S)-(+)-2,3-频二醇酯;(+)-蒎烷二醇异丁基硼酸酯;2-甲基丙基硼酸 (1S,2S,3R,5S)-(+)-2,3-蒎烷二醇酯 |
| 英文别名： |
(3aS,4S,6S,7aR)-2-Isobutyl-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborole;2-(2-methylpropyl)-(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborole;2-Methylpropaneboronic acid (1S,2S,3R,5S)-(+)-2,3-pinanediol ester;4,6-Methano-1,3,2-benzodioxaborole,hexahydro-3a,5,5-trimethyl-2-(2-methylpropyl)-, (3aS,4S,6S,7aR)-;Bortezomib Impurity 34;(1S,2S,6R,8S)-4-isobutyl-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0²⁶]decane;(3aS,4S,6S,7aR)-Hexahydro-3a,5,5-trimethyl-2-(2-methylpropyl)-4,6-methano-1,3,2-benzodioxaborole (ACI);4,6-Methano-1,3,2-benzodioxaborole, hexahydro-3a,5,5-trimethyl-2-(2-methylpropyl)-, [3aS-(3aα,4β,6β,7aα)]- (ZCI);(+)-Pinanediol 2-methylpropyl-1-boronate;2-(2-Methylpropyl)-(3aS,4S,6S,7aR)-hexahydro-3a,5,5-trimethyl-4,6-methano-1,3,2-benzodioxaborole |
沪公网安备 
